Ethical guidelines for our site US English Polish Italian Hungarian German Spanish UK English Australian English


   
in the news

understanding
your tests

inside the lab

about this site

site map

send us your
comments


home
 


Hormone Receptor Status

Also known as: Oestrogen receptors, Progesterone receptors
Formally known as: Oestrogen and Progesterone receptor status
Related tests: Her-2/neu, Tumour markers
The Test
 
How is it used?
When is it requested?
What does the test result mean?
Is there anything else I should know?

How is it used?
Hormone receptor status is used as a prognostic marker. Those with ER- and PR-positive tumours tend to have a better prognosis than those with ER- or PR-negative tumours.

The hormone receptor status test is also used to help determine treatment options, including endocrine therapy (anti-hormone treatments, such as tamoxifen), when a primary tumour has been removed or to help guide treatment decisions when a tumour recurs.



When is it requested?
Hormone receptor status testing is recommended as part of an initial workup of invasive breast cancer. It is not diagnostic but helps the doctor to determine treatment options and to understand more about the tumour's characteristics.



What does the test result mean?
In general, if a patient's cancer is ER- and PR-positive, the patient will have a better-than-average prognosis, and their cancer is likely to respond to endocrine therapy (anti-hormone treatments). The more receptors present and the more intense their reaction, the more likely the response. However, an individual's response depends on a variety of factors.

If a patient's cancer is ER-negative but PR-positive, the patient may still benefit from endocrine therapy but may have a diminished response.

If the cancer is both ER- and PR-negative, then the patient will probably not benefit from endocrine therapy.



Is there anything else I should know?
Her-2/neu testing may be done at the same time as hormone receptor status testing. A patient with a positive oestrogen and/or progesterone receptor status may find their response to endocrine therapy diminished if they are also Her-2/neu-positive.

Hormone receptor status testing is not available in every laboratory.




This page was last modified on May 13, 2004.
 

In the NewsUnderstanding Your TestsInside the Lab
About the SiteSite MapSend Us Your CommentsHome

If you don't know what a word or a medical term means Click Here to link to Stedmans Medical Dictionary

We comply with the HONcode standard for trustworthy health
information:
verify here.

©2004-07 all rights reserved
Email concerns to labtestsonlineuk@acb.org.uk

Terms of Use Privacy